25th Feb 2026 ADACCESS trial results comparing GP2017 (adalimumab biosimilar) and reference adalimumab treatments for plaque psoriasis: a plain language summary
25th Feb 2026 TASUKI-52 study of combination therapy using nivolumab, platinum chemotherapy, and bevacizumab for advanced or recurrent nonsquamous NSCLC: a plain language summary
25th Feb 2026 How the body handles lower-dose nilotinib tablet (Danziten™) versus capsule (Tasigna®): a plain language summary
25th Feb 2026 Plain language summary: DESTINY-Lung02 study of trastuzumab deruxtecan for HER2-mutant metastatic non-small-cell lung cancer
25th Feb 2026 Side-effect profile of brexpiprazole for agitation in people with Alzheimer’s dementia: a plain language summary
25th Feb 2026 Plain language summary of sparsentan clinical trial findings in patients with focal segmental glomerulosclerosis
25th Feb 2026 Managing specific adverse effects of teclistamab in multiple myeloma patients: a plain language summary
25th Feb 2026 Long-term outcomes of atacicept therapy in IgA nephropathy patients: a plain language summary
22nd Jan 2026 Meeting care goals through ongoing botulinum toxin therapy for leg spasticity in adults: plain language summary
28th Nov 2025 Apitegromab in young spinal muscular atrophy patients: SAPPHIRE study plain language summary
28th Nov 2025 TROPION-Lung01 trial for non-small cell lung cancer treatment: a plain language summary
28th Nov 2025 Plain language summary: TROPiCS-04 study of sacituzumab govitecan in advanced urinary tract cancer
26th Nov 2025 Plain language summary: real-world tafamidis study in transthyretin amyloid cardiomyopathy (ATTR-CM) patients
28th Oct 2025 Plain language summary: AI-based monitoring of geographic atrophy treatment with pegcetacoplan
28th Oct 2025 ERICA study plain language summary: olanzapine for nausea in breast cancer patients on trastuzumab deruxtecan
28th Oct 2025 CEPHEUS study: daratumumab combination therapy for newly diagnosed multiple myeloma: plain language summary
28th Oct 2025 CheckMate 7FL trial: nivolumab versus placebo in estrogen-positive breast cancer treatment: plain language summary
23rd Oct 2025 Plain language summary of the IMerge Phase 3 study: imetelstat vs placebo in lower-risk myelodysplastic syndrome patients with anemia
23rd Oct 2025 Recent insights on vagus nerve stimulation’s role in epilepsy: a plain language summary
22nd Sep 2025 LOCK IT-100 study: A plain language summary of the taurolidine/heparin catheter lock solution
22nd Sep 2025 A plain language summary of the LUMINA-1 study: bone imaging in patients with fibrodysplasia ossificans progressiva
19th Sep 2025 A plain language summary of the MonumenTAL-1 study: talquetamab for relapsed/ refractory multiple myeloma
16th Sep 2025 Plain language summary: Global Registry data shows patients with aHUS can safely and effectively change from eculizumab to ravulizumab treatment
15th Sep 2025 Evaluating an OX40 ligand-blocking antibody for eczema treatment in the STREAM-AD clinical trial: a plain language summary
15th Sep 2025 Plain language summary: testing sacituzumab govitecan in metastatic bladder cancer patients after immunotherapy when standard chemotherapy isn’t an option
28th Aug 2025 Examining empagliflozin’s safety profile across four clinical trials: a plain language summary
28th Aug 2025 Plain language summary: using matched patient data to evaluate omaveloxolone against the natural history of Friedreich ataxia
28th Aug 2025 DISCOVERY study findings on pegcetacoplan for treating rare kidney diseases linked to complement system dysfunction: plain language summary
15th Aug 2025 Plain language summary: examining the effectiveness, safety, and longevity of a new bioprosthetic aortic valve replacement
30th Jul 2025 Plain language summary: 4-year outcomes from testing valoctocogene roxaparvovec gene therapy in people with hemophilia A
18th Jul 2025 Plain language summary: living with advancing pulmonary fibrosis – patient experiences and treatment approaches
17th Jul 2025 Plain language summary: research on taking rimegepant by mouth to reduce migraine frequency
17th Jul 2025 Plain language summary: understanding how people with asthma or COPD and their healthcare providers make decisions about treatment
17th Jul 2025 Plain language summary: the long-term benefits and safety of evinacumab treatment for people with a severe inherited cholesterol disorder
25th Jun 2025 Treating pulmonary arterial hypertension with oral treprostinil tablets (Orenitram): a plain language summary
25th Jun 2025 Plain language summary: benefits of SGLT2 inhibitor medications for people living with chronic kidney disease
25th Jun 2025 Plain language summary: how following multiple sclerosis medication prescriptions affects disease flare-ups, physical limitations, and medical expenses
24th Jun 2025 Plain language summary: two key studies on acalabrutinib’s efficacy and safety profile for treating patients with previously treated chronic lymphocytic leukemia/small lymphocytic lymphoma
